Pamisel, Top Search Ranking... Stock Price -1.88%
Pamissel has ranked among the top searched stocks for 10 days in the past month.
As of 9:30 AM on the 8th, Pamissel is trading at 20,850 KRW, down 1.88% from the previous day. This represents a 10.71% decline compared to November 18. Pamissel is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Over the past five days, individual investors have net purchased 227,768 shares, while foreigners and institutions have net sold 230,959 shares and net purchased 23,178 shares, respectively.
On December 3, Pamissel was a market topic with the headline "Strong performance following approval of phase 3 clinical trial for liver cirrhosis stem cell therapy."
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
